In pancreatic cancer xenograft models, Zhu et al. demonstrated that CSF-1R blockade with PLX-3397 decreased CD206 TAMs (i.e. M2 phenotype macrophage) within the TME and reprogrammed the remaining TAMs towards an anti-tumor phenotype [24]. The gene discussed is CSF1R; the disease is pancreatic neoplasm.